Avalyn Pharma Statistics
NASDAQ: AVLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
25.53+0.10 (+0.39%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Avalyn Pharma by the numbers
Avalyn Pharma has a market capitalization of $1.13 billion based on 44.33M shares outstanding. With trailing EPS of $-2.47, Avalyn Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.2% below its 50-day average and 17.0% below its 200-day average.
Average daily trading volume is 238.20K shares, or about $6.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AVLN valuation vs. peer median
| Metric | AVLN | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.13B | $1.09B | +3% |
| Avg. volume | 238.20K | 699.31K | -66% |
Peer median across 8 companies: MNKD, HROW, LBRX, JANX, TRAX, BCAX, AMPH, OPK.
Valuation
- Market cap
- $1.13B
- EPS (TTM)
- $-2.47
- Shares outstanding
- 44.33M
Price and trading
- Previous close
- 25.43
- Open
- 25.30
- Day range
- 25.26 – 26.31
- 52-week range
- 24.15 – 40.17
- Beta
- —
- Volume
- 202.93K
- Average volume
- 238.20K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 1.13B
- Forward Pe
- -13.44
- Eps
- -2.47
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.17
- Week52 Low
- 24.15
- Avg Volume
- 238.20K
- Shares Outstanding
- 44.33M
- Ma50
- 33.24
- Ma200
- 30.78
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -36.45%
- Pct From52w Low
- 5.71%